BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 15732445)

  • 21. Carisoprodol use and abuse in Norway: a pharmacoepidemiological study.
    Bramness JG; Furu K; Engeland A; Skurtveit S
    Br J Clin Pharmacol; 2007 Aug; 64(2):210-8. PubMed ID: 17298482
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of scheduling and withdrawal of carisoprodol on prevalence of intoxications with the drug.
    Høiseth G; Karinen R; Sørlid HK; Bramness JG
    Basic Clin Pharmacol Toxicol; 2009 Nov; 105(5):345-9. PubMed ID: 19663822
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Carisoprodol legal status and patterns of abuse.
    Fass JA
    Ann Pharmacother; 2010 Dec; 44(12):1962-7. PubMed ID: 21062909
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Carisoprodol--one more time].
    Reiestad F; Fagerlund B
    Tidsskr Nor Laegeforen; 2002 Jan; 122(3):327. PubMed ID: 11894608
    [No Abstract]   [Full Text] [Related]  

  • 25. Pharmacokinetic modeling of carisoprodol and meprobamate disposition in adults.
    Lewandowski TA
    Hum Exp Toxicol; 2017 Aug; 36(8):846-853. PubMed ID: 27758843
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Carisoprodol should be taken off the market.
    Bramness JG; Skurtveit S
    South Med J; 2008 Oct; 101(10):1074-5. PubMed ID: 18791514
    [No Abstract]   [Full Text] [Related]  

  • 27. Carisoprodol: an underrecognized drug of abuse in north India.
    Nebhinani N; Aggarwal M; Mattoo SK; Basu D
    Gen Hosp Psychiatry; 2013; 35(1):89-92. PubMed ID: 22959419
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tolerance and dependence risk with the use of carisoprodol.
    Heacock C; Bauer MS
    Am Fam Physician; 2004 Apr; 69(7):1622-3. PubMed ID: 15086035
    [No Abstract]   [Full Text] [Related]  

  • 29. Carisoprodol-induced amnestic state and nocturnal blackouts.
    Hussain HM; Usman A; Butt MU
    Aust N Z J Psychiatry; 2008 Oct; 42(10):909-11. PubMed ID: 18792430
    [No Abstract]   [Full Text] [Related]  

  • 30. Urticaria to carisoprodol.
    Fernández-Rivas M; González Mancebo E
    Allergy; 2002 Jan; 57(1):55. PubMed ID: 11991293
    [No Abstract]   [Full Text] [Related]  

  • 31. Treatment of carisoprodol dependence: a case report.
    Rohatgi G; Rissmiller DJ; Gorman JM
    J Psychiatr Pract; 2005 Sep; 11(5):347-52. PubMed ID: 16184075
    [No Abstract]   [Full Text] [Related]  

  • 32. Carisoprodol abuse in Mississippi.
    Reeves RR; Henderson RH; Ladner ME
    J Miss State Med Assoc; 2007 Dec; 48(12):363-5. PubMed ID: 19292137
    [No Abstract]   [Full Text] [Related]  

  • 33. The risk of traffic accidents after prescriptions of carisoprodol.
    Bramness JG; Skurtveit S; Mørland J; Engeland A
    Accid Anal Prev; 2007 Sep; 39(5):1050-5. PubMed ID: 17854578
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Abuse of Carisoprodol].
    Lindberg N; Lauerma H
    Duodecim; 1996; 112(2):109-11. PubMed ID: 10590614
    [No Abstract]   [Full Text] [Related]  

  • 35. The serotonin toxidrome: shortfalls of current diagnostic criteria for related syndromes.
    Chiew AL; Buckley NA
    Clin Toxicol (Phila); 2022 Feb; 60(2):143-158. PubMed ID: 34806513
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Use of carisoprodol (Somadril)].
    Rygnestad T; Aamo T
    Tidsskr Nor Laegeforen; 1997 Mar; 117(7):1004-5. PubMed ID: 9102996
    [No Abstract]   [Full Text] [Related]  

  • 37. Simultaneous determination of carisoprodol and acetaminophen in an attempted suicide by liquid chromatography-mass spectrometry with positive electrospray ionization.
    Matsumoto T; Sano T; Matsuoka T; Aoki M; Maeno Y; Nagao M
    J Anal Toxicol; 2003 Mar; 27(2):118-22. PubMed ID: 12670008
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A rapid quantitative method of carisoprodol and meprobamate by liquid chromatography-tandem mass spectrometry.
    Essler S; Bruns K; Frontz M; McCutcheon JR
    J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Nov; 908():155-60. PubMed ID: 23040985
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of the market withdrawal of carisoprodol on use of other prescribed drugs with abuse potential.
    Bramness JG; Furu K; Skurtveit S; Engeland A
    Clin Pharmacol Ther; 2012 Mar; 91(3):438-41. PubMed ID: 22318620
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Abuse potential of carisoprodol: a retrospective review of Idaho Medicaid pharmacy and medical claims data.
    Owens C; Pugmire B; Salness T; Culbertson V; Force R; Cady P; Steiner J
    Clin Ther; 2007 Oct; 29(10):2222-5. PubMed ID: 18042478
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.